Plus   Neg

Neuralstem Inc. (CUR) Surged To A 4-Month High On Study Results

Neuralstem Inc. (CUR) announced Tuesday that the 40 mg dose of NSI-189 showed statistically significant improvement on Cogscreen objective cognitive measures of attention and memory in its Phase 2 study.

Neuralstem climbed during the first 45 minutes of trade Tuesday and advanced further going into the close. The stock ended the day with a gain of 1.97 at $3.09 on the highest volume of the year. Neuralstem broke out of a trading range and set over a 4-month high.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT